Publicaciones en colaboración con investigadores/as de Hospital San Pedro (14)

2024

  1. Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer

    Cancers, Vol. 16, Núm. 5

2022

  1. CCL5 Levels Predict Stroke Volume Growth in Acute Ischemic Stroke and Significantly Diminish in Hemorrhagic Stroke Patients

    International journal of molecular sciences, Vol. 23, Núm. 17

  2. Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Adrenomedullin is a diagnostic and prognostic biomarker for acute intracerebral hemorrhage

    Current Issues in Molecular Biology, Vol. 43, Núm. 1, pp. 324-334

  2. Response to Letter to the Editor from Abobaker and Darrat: "circulating levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients"

    Journal of the Endocrine Society

2017

  1. Lack of adrenomedullin aggravates acute tnbs-induced colitis symptoms in mice, especially in females

    Frontiers in Physiology, Vol. 8, Núm. DEC

  2. Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas

    Histochemistry and Cell Biology, Vol. 146, Núm. 4, pp. 467-477

  2. Temporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patients

    Molecular Medicine Reports, Vol. 13, Núm. 5, pp. 3724-3734

2015

  1. Shorter telomere length predicts poorer immunological recovery in virologically suppressed hiv-1-infected patients treated with combined antiretroviral therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 68, Núm. 1, pp. 21-29

2014

  1. Transcriptomic profiling explains racial disparities in pterygium patients treated with doxycycline

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 11, pp. 7553-7561

2013

  1. Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing

    PLoS ONE, Vol. 7, Núm. 6

  2. Oral Doxycycline Reduces Pterygium Lesions; Results from a Double Blind, Randomized, Placebo Controlled Clinical Trial

    PLoS ONE, Vol. 7, Núm. 12